BioLife Solutions, Inc. (BLFS)Healthcare | Medical Instruments & Supplies | Bothell, United States | NasdaqCM
36.38 USD
-0.82
(-2.204%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 36.38 |
Hot Take ↕ | Aug. 22, 2026, 4:16 a.m. EDT
The immediate outlook is aggressively bullish, driven by a confirmed $1.5 billion acquisition by Repligen which provides a clear exit strategy and validates the company's technology. This corporate catalyst has ignited a speculative frenzy, with options data showing heavy call buying and minimal hedging, suggesting traders are positioning for a rapid price appreciation toward the deal value. However, the long-term investment case is fundamentally compromised; despite impressive historical growth, the stock trades at a premium valuation with forward earnings estimates that imply a massive multiple expansion, and the impending sale removes the independent growth story investors typically seek. With no dividend to provide income and the business effectively being sold off, the equity's intrinsic value is likely to diminish post-merger, making this a high-conviction short-term momentum play rather than a sustainable long-term hold. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.049371 |
| MSTL | 0.067503 |
| AutoETS | 0.067528 |
| AutoARIMA | 0.162991 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 0.18 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.910 |
| Excess Kurtosis | 0.28 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.747 |
| Revenue per Share | 2.207 |
| Market Cap | 1,779,225,984 |
| Trailing P/E | 36.38 |
| Forward P/E | 110.24 |
| Beta | 1.90 |
| Profit Margins | 54.35% |
| Website | https://www.biolifesolutions.com |
As of Aug. 22, 2026, 4:16 a.m. EDT: Speculators are overwhelmingly bullish, evidenced by massive open interest in in-the-money calls (strikes 30 and 35) compared to negligible put activity. The call chain shows significant positioning at strikes well above the current price, while the put side is virtually dormant except for deep out-of-the-money contracts, indicating a strong consensus for continued upside rather than downside protection.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.46803474 |
| Address1 | 3,303 Monte Villa Parkway |
| Address2 | Suite 310 |
| All Time High | 1,382.5 |
| All Time Low | 0.14 |
| Ask | 46.98 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 736,440 |
| Average Daily Volume3 Month | 1,107,998 |
| Average Volume | 1,107,998 |
| Average Volume10Days | 736,440 |
| Beta | 1.896 |
| Bid | 26.5 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 8.591 |
| City | Bothell |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 36.38 |
| Current Ratio | 9.694 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 37.19 |
| Day Low | 36.36 |
| Debt To Equity | 3.747 |
| Display Name | BioLife |
| Earnings Call Timestamp End | 1,778,185,800 |
| Earnings Call Timestamp Start | 1,778,185,800 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | 6,900,000 |
| Ebitda Margins | 0.06467 |
| Enterprise To Ebitda | 248.195 |
| Enterprise To Revenue | 16.052 |
| Enterprise Value | 1,712,547,840 |
| Eps Current Year | 0.25 |
| Eps Forward | 0.33 |
| Eps Trailing Twelve Months | 1.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 425 402 1433 |
| Fifty Day Average | 31.1704 |
| Fifty Day Average Change | 5.2096004 |
| Fifty Day Average Change Percent | 0.16713293 |
| Fifty Two Week Change Percent | 46.803474 |
| Fifty Two Week High | 38.1 |
| Fifty Two Week High Change | -1.7199974 |
| Fifty Two Week High Change Percent | -0.04514429 |
| Fifty Two Week Low | 17.86 |
| Fifty Two Week Low Change | 18.52 |
| Fifty Two Week Low Change Percent | 1.036954 |
| Fifty Two Week Range | 17.86 - 38.1 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 627,748,200,000 |
| Float Shares | 42,833,469 |
| Forward Eps | 0.33 |
| Forward P E | 110.242424 |
| Free Cashflow | 4,664,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 155 |
| Fullday Change | -0.82 |
| Fullday Change Percent | -2.2043 |
| Fullday Price | 36.38 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.63613 |
| Gross Profits | 67,867,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0242 |
| Held Percent Institutions | 1.05515 |
| Implied Shares Outstanding | 48,906,704 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,390,953,600 |
| Last Split Factor | 1:14 |
| Long Business Summary | BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington. |
| Long Name | BioLife Solutions, Inc. |
| Market | us_market |
| Market Cap | 1,779,225,984 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_265126 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 49,210,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,819,329,388 |
| Number Of Analyst Opinions | 7 |
| Open | 37.05 |
| Operating Cashflow | 16,877,000 |
| Operating Margins | 0.059580002 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 15.09 |
| Phone | 425 402 1400 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 36.38 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 37.2 |
| Price Eps Current Year | 145.52 |
| Price Hint | 2 |
| Price To Book | 4.2346644 |
| Price To Sales Trailing12 Months | 16.676908 |
| Profit Margins | 0.54346 |
| Quick Ratio | 6.673 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.82 |
| Regular Market Change Percent | -2.2043 |
| Regular Market Day High | 37.19 |
| Regular Market Day Low | 36.36 |
| Regular Market Day Range | 36.36 - 37.19 |
| Regular Market Open | 37.05 |
| Regular Market Previous Close | 37.2 |
| Regular Market Price | 36.38 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 1,041,874 |
| Return On Assets | 0.00262 |
| Return On Equity | 0.12829 |
| Revenue Growth | 0.215 |
| Revenue Per Share | 2.207 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 48,906,704 |
| Shares Percent Shares Out | 0.082100004 |
| Shares Short | 4,017,528 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,856,425 |
| Short Name | BioLife Solutions, Inc. |
| Short Percent Of Float | 0.1285 |
| Short Ratio | 2.9 |
| Source Interval | 15 |
| State | WA |
| Symbol | BLFS |
| Target High Price | 33.0 |
| Target Low Price | 31.0 |
| Target Mean Price | 31.28571 |
| Target Median Price | 31.0 |
| Total Cash | 82,416,000 |
| Total Cash Per Share | 1.685 |
| Total Debt | 15,738,000 |
| Total Revenue | 106,688,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.0 |
| Trailing P E | 36.38 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 25.1236 |
| Two Hundred Day Average Change | 11.256401 |
| Two Hundred Day Average Change Percent | 0.44804093 |
| Type Disp | Equity |
| Volume | 1,041,874 |
| Website | https://www.biolifesolutions.com |
| Zip | 98,021 |